China Cash vs Total Stockholder Equity Analysis

600511 Stock

32.56 0.18 0.55%

China National financial indicator trend analysis is way more than just evaluating China National Medicines prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether China National Medicines is a good investment. Please check the relationship between China National Cash and its Total Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China National Medicines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Cash vs Total Stockholder Equity

Cash vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of China National Medicines Cash account and Total Stockholder Equity. At this time, the significance of the direction appears to have totally related.

The correlation between China National's Cash and Total Stockholder Equity is 0.99. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of China National Medicines, assuming nothing else is changed. The correlation between historical values of China National's Cash and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of China National Medicines are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Cash i.e., China National's Cash and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.99

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Cash

Cash refers to the most liquid asset of China National Medicines, which is listed under current asset account on China National Medicines balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from China National customers. The amounts must be unrestricted with restricted cash listed in a different China National account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most indicators from China National's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into China National Medicines current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China National Medicines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

As of January 6, 2025, Selling General Administrative is expected to decline to about 459.3 M. In addition to that, Tax Provision is expected to decline to about 495.7 M

	2022	2023	2024	2025 (projected)
Operating Income	2.4B	2.5B	2.8B	3.0B
Total Revenue	45.5B	49.7B	57.2B	60.0B

Operating Income Total Revenue

China National fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Accounts Payable	Cash	Other Assets	Net Receivables	Inventory	Other Current Assets	Total Liab	Common Stock	Property Plant Equipment	Retained Earnings	Long Term Debt	Intangible Assets	Other Liab	Short Term Investments	Good Will	Net Tangible Assets	Other Stockholder Equity	Deferred Long Term Liab	Long Term Investments	Total Current Assets	Non Current Assets Total	Non Currrent Assets Other
Total Assets		0.07	0.97	1.0	0.96	0.98	0.96	0.75	0.96	-0.07	1.0	0.7	0.89	0.98	-0.43	0.99	0.87	0.48	0.92	0.93	-0.9	0.91	0.86	0.94	0.91	0.84
Other Current Liab	0.07		0.19	0.01	0.19	-0.09	0.13	0.32	0.15	0.88	0.11	0.42	0.18	-0.03	-0.16	0.16	-0.22	0.13	0.3	0.21	-0.38	0.16	0.27	0.17	-0.13	-0.33
Total Current Liabilities	0.97	0.19		0.96	1.0	0.94	0.97	0.85	1.0	0.02	0.97	0.72	0.9	0.96	-0.47	0.97	0.82	0.51	0.89	0.92	-0.91	0.87	0.84	0.96	0.84	0.76
Total Stockholder Equity	1.0	0.01	0.96		0.96	0.99	0.96	0.72	0.96	-0.13	0.99	0.67	0.89	0.99	-0.43	0.98	0.89	0.47	0.9	0.92	-0.86	0.91	0.85	0.94	0.92	0.86
Accounts Payable	0.96	0.19	1.0	0.96		0.93	0.97	0.85	0.99	0.02	0.96	0.71	0.9	0.96	-0.46	0.97	0.82	0.51	0.88	0.92	-0.9	0.87	0.85	0.96	0.84	0.76
Cash	0.98	-0.09	0.94	0.99	0.93		0.94	0.71	0.94	-0.23	0.97	0.61	0.85	0.99	-0.43	0.96	0.91	0.44	0.86	0.89	-0.82	0.87	0.8	0.91	0.92	0.88
Other Assets	0.96	0.13	0.97	0.96	0.97	0.94		0.76	0.97	-0.01	0.96	0.75	0.91	0.96	-0.3	0.94	0.88	0.63	0.87	0.91	-0.86	0.88	0.81	0.92	0.85	0.79
Net Receivables	0.75	0.32	0.85	0.72	0.85	0.71	0.76		0.86	0.25	0.77	0.65	0.71	0.72	-0.43	0.8	0.48	0.48	0.71	0.7	-0.83	0.58	0.67	0.77	0.56	0.44
Inventory	0.96	0.15	1.0	0.96	0.99	0.94	0.97	0.86		0.02	0.96	0.72	0.91	0.96	-0.43	0.97	0.82	0.55	0.87	0.91	-0.9	0.86	0.85	0.95	0.84	0.76
Other Current Assets	-0.07	0.88	0.02	-0.13	0.02	-0.23	-0.01	0.25	0.02		-0.02	0.35	0.04	-0.18	0.11	0.0	-0.35	0.16	0.15	0.04	-0.26	-0.03	0.16	0.0	-0.25	-0.47
Total Liab	1.0	0.11	0.97	0.99	0.96	0.97	0.96	0.77	0.96	-0.02		0.73	0.89	0.97	-0.42	0.99	0.84	0.49	0.93	0.93	-0.92	0.9	0.86	0.94	0.89	0.81
Common Stock	0.7	0.42	0.72	0.67	0.71	0.61	0.75	0.65	0.72	0.35	0.73		0.73	0.63	-0.05	0.72	0.49	0.65	0.82	0.8	-0.79	0.76	0.81	0.78	0.68	0.43
Property Plant Equipment	0.89	0.18	0.9	0.89	0.9	0.85	0.91	0.71	0.91	0.04	0.89	0.73		0.9	-0.24	0.89	0.74	0.69	0.8	0.83	-0.76	0.82	0.77	0.83	0.77	0.74
Retained Earnings	0.98	-0.03	0.96	0.99	0.96	0.99	0.96	0.72	0.96	-0.18	0.97	0.63	0.9		-0.43	0.96	0.91	0.47	0.86	0.91	-0.83	0.9	0.83	0.93	0.92	0.87
Long Term Debt	-0.43	-0.16	-0.47	-0.43	-0.46	-0.43	-0.3	-0.43	-0.43	0.11	-0.42	-0.05	-0.24	-0.43		-0.49	-0.25	0.39	-0.46	-0.47	0.51	-0.43	-0.43	-0.49	-0.37	-0.33
Intangible Assets	0.99	0.16	0.97	0.98	0.97	0.96	0.94	0.8	0.97	0.0	0.99	0.72	0.89	0.96	-0.49		0.8	0.45	0.94	0.93	-0.93	0.9	0.87	0.95	0.87	0.8
Other Liab	0.87	-0.22	0.82	0.89	0.82	0.91	0.88	0.48	0.82	-0.35	0.84	0.49	0.74	0.91	-0.25	0.8		0.46	0.7	0.79	-0.63	0.79	0.67	0.8	0.87	0.81
Short Term Investments	0.48	0.13	0.51	0.47	0.51	0.44	0.63	0.48	0.55	0.16	0.49	0.65	0.69	0.47	0.39	0.45	0.46		0.34	0.36	-0.36	0.33	0.32	0.38	0.33	0.34
Good Will	0.92	0.3	0.89	0.9	0.88	0.86	0.87	0.71	0.87	0.15	0.93	0.82	0.8	0.86	-0.46	0.94	0.7	0.34		0.97	-0.95	0.95	0.95	0.95	0.87	0.69
Net Tangible Assets	0.93	0.21	0.92	0.92	0.92	0.89	0.91	0.7	0.91	0.04	0.93	0.8	0.83	0.91	-0.47	0.93	0.79	0.36	0.97		-0.91	0.98	0.96	0.99	0.93	0.75
Other Stockholder Equity	-0.9	-0.38	-0.91	-0.86	-0.9	-0.82	-0.86	-0.83	-0.9	-0.26	-0.92	-0.79	-0.76	-0.83	0.51	-0.93	-0.63	-0.36	-0.95	-0.91		-0.84	-0.89	-0.91	-0.77	-0.6
Deferred Long Term Liab	0.91	0.16	0.87	0.91	0.87	0.87	0.88	0.58	0.86	-0.03	0.9	0.76	0.82	0.9	-0.43	0.9	0.79	0.33	0.95	0.98	-0.84		0.94	0.95	0.95	0.79
Long Term Investments	0.86	0.27	0.84	0.85	0.85	0.8	0.81	0.67	0.85	0.16	0.86	0.81	0.77	0.83	-0.43	0.87	0.67	0.32	0.95	0.96	-0.89	0.94		0.93	0.88	0.66
Total Current Assets	0.94	0.17	0.96	0.94	0.96	0.91	0.92	0.77	0.95	0.0	0.94	0.78	0.83	0.93	-0.49	0.95	0.8	0.38	0.95	0.99	-0.91	0.95	0.93		0.93	0.76
Non Current Assets Total	0.91	-0.13	0.84	0.92	0.84	0.92	0.85	0.56	0.84	-0.25	0.89	0.68	0.77	0.92	-0.37	0.87	0.87	0.33	0.87	0.93	-0.77	0.95	0.88	0.93		0.86
Non Currrent Assets Other	0.84	-0.33	0.76	0.86	0.76	0.88	0.79	0.44	0.76	-0.47	0.81	0.43	0.74	0.87	-0.33	0.8	0.81	0.34	0.69	0.75	-0.6	0.79	0.66	0.76	0.86

Click cells to compare fundamentals

China National Account Relationship Matchups

China National fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	24.9B	27.5B	29.6B	32.5B	37.3B	39.2B
Other Current Liab	1.2B	1.5B	1.0M	1.2M	1.4M	1.3M
Total Current Liabilities	11.2B	12.7B	12.7B	13.9B	16.0B	16.8B
Total Stockholder Equity	11.4B	12.8B	14.2B	15.8B	18.1B	19.0B
Accounts Payable	9.0B	10.1B	9.9B	10.9B	12.6B	13.2B
Cash	6.2B	7.3B	8.9B	10.9B	12.6B	13.2B
Other Assets	242.6M	283.9M	299.0M	345.4M	397.2M	417.1M
Net Receivables	5.4B	5.7B	5.7B	9.0B	10.3B	10.8B
Inventory	3.0B	3.5B	3.7B	4.0B	4.6B	4.8B
Other Current Assets	198.6M	280.6M	14.5M	8.7M	10.0M	9.5M
Total Liab	11.8B	13.1B	13.7B	14.9B	17.2B	18.0B
Property Plant Equipment	628.5M	832.7M	895.7M	845.1M	971.8M	1.0B
Retained Earnings	8.3B	9.7B	10.5B	12.0B	13.8B	14.5B
Intangible Assets	330.4M	326.2M	330.9M	386.1M	444.0M	466.2M
Other Liab	233.2M	265.0M	313.7M	718.4M	826.2M	867.5M
Net Tangible Assets	8.8B	10.1B	11.0B	12.3B	14.2B	9.2B
Other Stockholder Equity	15.9M	22.5M	27.7M	24.9M	22.4M	25.5M
Deferred Long Term Liab	56.8M	71.8M	90.3M	89.6M	103.0M	68.2M
Total Current Assets	22.1B	24.5B	25.8B	28.3B	32.5B	22.0B
Non Current Assets Total	2.8B	3.0B	3.8B	4.2B	4.8B	3.0B
Non Currrent Assets Other	674.8M	139.6M	686.7M	686.0M	789.0M	828.4M
Non Current Liabilities Total	573.8M	491.1M	1.0B	1.0B	1.2B	1.2B
Non Current Liabilities Other	178.1M	226.6M	215.2M	747.1M	859.2M	902.2M
Net Invested Capital	11.9B	13.2B	14.5B	16.0B	18.5B	13.5B
Short Long Term Debt	471.8M	428.8M	252.1M	268.4M	241.5M	456.0M
Net Working Capital	10.9B	11.8B	13.0B	14.4B	16.5B	12.1B
Property Plant And Equipment Net	895.7M	845.1M	857.9M	827.0M	744.3M	681.4M
Capital Lease Obligations	260.1M	197.3M	182.6M	205.1M	184.6M	161.9M
Property Plant And Equipment Gross	1.3B	1.4B	1.4B	827.0M	744.3M	992.3M

Currently Active Assets on Macroaxis

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin
ADA	Cardano
XRP	XRP

Other Information on Investing in China Stock

Balance Sheet is a snapshot of the financial position of China National Medicines at a specified time, usually calculated after every quarter, six months, or one year. China National Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of China National and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which China currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

China Cash vs Total Stockholder Equity Analysis

Cash vs Total Stockholder Equity

Cash vs Total Stockholder Equity Correlation Analysis

Correlation Coefficient

Cash

Total Stockholder Equity

China National fundamental ratios Correlations

China National Account Relationship Matchups

High Positive Relationship

High Negative Relationship

China National fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in China Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Assets
Accounts Payable	+ 1.0	Total Current Liabilities
Inventory	+ 1.0	Total Current Liabilities
Intangible Assets	+ 0.99	Total Assets
Cash	+ 0.99	Total Stockholder Equity

Other Stockholder Equity	- 0.95	Good Will
Other Stockholder Equity	- 0.93	Intangible Assets
Other Stockholder Equity	- 0.92	Total Liab
Total Current Assets	- 0.91	Other Stockholder Equity
Other Stockholder Equity	- 0.91	Net Tangible Assets
Other Stockholder Equity	- 0.91	Total Current Liabilities